DeepMed Research

University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

GI-4000 With Adoptive Transfer in Pancreatic Cancer

Phase 1

Withdrawn

Conditions: Pancreatic Cancer

Interventions: Other: Screening
Biological: GI-4000 Vaccine + Activated T Cells
Biological: GI-4000 Vaccine
Biological: Surgical Evaluation after Vaccine #4

First Posted Date: 2009-02-05

Last Posted Date: 2016-08-17

Lead Sponsor: University of Pennsylvania

Registration Number: NCT00837135

Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Biological: hTERT vaccine, GM-CSF, PCV, T cell infusion
Biological: GM-CSF, PCV, T cell infusion

First Posted Date: 2009-02-03

Last Posted Date: 2019-10-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 59

Registration Number: NCT00834665

Locations: 🇺🇸
Greenbaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Biomarkers for Obstructive Sleep Apnea

Completed

Conditions: Obstructive Sleep Apnea (OSA)

Interventions: Device: CPAP

First Posted Date: 2009-02-03

Last Posted Date: 2017-04-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 181

Registration Number: NCT00834509

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Improving the Management of Obesity in Primary Care Practice (The Power-UP Trial)

Phase 3

Completed

Conditions: Diabetes
Obesity
Hypercholesterolemia
Metabolic Syndrome
Hypertension

Interventions: Behavioral: Usual Care
Behavioral: Brief Lifestyle Counseling
Behavioral: Enhanced Brief Lifestyle Counseling

First Posted Date: 2009-01-22

Last Posted Date: 2012-05-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 390

Registration Number: NCT00826774

Understanding Treatment Response With Naltrexone Among White Alcoholics

Phase 4

Completed

Conditions: Alcoholism

Interventions: Drug: Placebo Oral Tablet
Drug: Naltrexone

First Posted Date: 2009-01-06

Last Posted Date: 2019-11-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 24

Registration Number: NCT00817089

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)

Phase 3

Completed

Conditions: Respiratory Distress Syndrome, Newborn
Lung Diseases
Respiratory Insufficiency

Interventions: Behavioral: Team approach to sedation management
Behavioral: Usual approach to sedation management

First Posted Date: 2008-12-23

Last Posted Date: 2015-07-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2449

Registration Number: NCT00814099

Locations: 🇺🇸
Johns Hopkins Children's Center, Baltimore, Maryland, United States
🇺🇸
University of Massachusetts Memorial Children's Medical Center, Worcester, Massachusetts, United States
🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States

and more 28 locations

The Testosterone Trials in Older Men

Phase 3

Completed

Conditions: Andropause

Interventions: Drug: AndroGel® (testosterone gel)
Drug: Placebo

First Posted Date: 2008-12-01

Last Posted Date: 2019-02-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 790

Registration Number: NCT00799617

Locations: 🇺🇸
Center for Men's Health LA BioMed at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 9 locations

Patient Feedback Effectiveness Study

Not Applicable

Completed

Conditions: Substance Use Disorders

Interventions: Behavioral: Patient Feedback

First Posted Date: 2008-11-25

Last Posted Date: 2012-01-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 118

Registration Number: NCT00798044

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure

Phase 2

Completed

Conditions: Congestive Heart Failure

Interventions: Drug: Growth hormone releasing hormone/ placebo

First Posted Date: 2008-11-17

Last Posted Date: 2019-07-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT00791843

Locations: 🇺🇸
Massachusetts General Hospital/ Geriatric Research, Boston, Massachusetts, United States

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site

Phase 2

Completed

Conditions: Opiate Addiction

Interventions: Other: Treatment as Usual (TAU)
Drug: Depot naltrexone

First Posted Date: 2008-10-29

Last Posted Date: 2017-10-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 308

Registration Number: NCT00781898

Locations: 🇺🇸
Treatment Research Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy